Creo Medical Group PLC (LON:CREO – Get Free Report) dropped 2.8% during trading on Monday . The company traded as low as GBX 34 ($0.42) and last traded at GBX 34.25 ($0.43). Approximately 443,396 shares changed hands during trading, a decline of 45% from the average daily volume of 809,068 shares. The stock had previously closed at GBX 35.25 ($0.44).
Creo Medical Group Trading Up 2.2 %
The business’s 50-day moving average price is GBX 35.13 and its 200 day moving average price is GBX 36.19. The company has a debt-to-equity ratio of 13.33, a current ratio of 4.13 and a quick ratio of 2.19. The firm has a market capitalization of £126.51 million, a price-to-earnings ratio of -311.36 and a beta of 0.84.
About Creo Medical Group
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Featured Articles
- Five stocks we like better than Creo Medical Group
- Trading Halts Explained
- United Airlines Soars on Earnings Beat
- What Does a Stock Split Mean?
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
